GlaxoSmithKline to sell soft drink brands Lucozade and Ribena
date:Apr 25, 2013
sche Bank said they believed the two brands should bring in more than 1.5 billion pounds.

MATURE PRODUCTS SPIN-OFF?

GSK also said it was creating a new global established products portfolio, consisting of around 50 medicines with annual sales of some 3 billion pounds, including stomach acid treatments Tagamet and Zantac, Imitrex for migraine, and anti-nausea treatment Zofran.

Witty said placing these so-called tail products in a division that would report separately from next January opened v
5/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/01 17:41